Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (4)
  • 2024 (9)
  • 2023 (13)
  • 2022 (19)
  • 2021 (19)
  • 2020 (7)
  • 2019 (2)
  • 2018 (2)

Subject

  • Drug Trafficking (33)
  • Pharmaceuticals/Pharmacists/Physicians (12)
  • Diversion Division (10)
  • Fake Pills (10)
  • Synthetic drugs (8)
  • Guns/Weapons (7)
  • OCDETF/Task Force (6)
  • Seizures (Drugs/Property) (6)
  • Task Forces/Task Force Officers (6)
  • Overdose (4)
  • Major Law Enforcement Operation (3)
  • Arrests/Convictions - Major (2)
  • Guilty Plea (2)
  • Asset Forfeiture (1)
  • Dark Web- Internet Trafficking (1)
  • Public and Media Affairs - also see Congressional Affairs (1)
  • Take Back Day (1)
  • Prescription Drugs (19)

Drug Name

  • Opioids (18)
  • Fentanyl (13)
  • Hydromorphone (10)
  • Synthetic Opioids (6)
  • Benzodiazepines (4)
  • Amphetamines (3)
  • Cocaine (3)
  • Heroin (2)
  • Methadone (2)
  • Methamphetamine (2)
  • Morphine (2)
  • Steroids (2)
  • Marijuana (Cannabis) (1)
  • Oxycodone (19)

Field Division

  • Washington, DC (5)
  • Atlanta (4)
  • New York (3)
  • New England (2)
  • Chicago (1)
  • Miami (1)
  • New Jersey (1)
  • Seattle (1)
  • St. Louis (1)
Clear All Results
PRESS RELEASE

Northeast Hospital Agrees to Pay $1.9 Million To Resolve Allegations of Controlled Substance Recordkeeping Violations

Diciembre 07, 2022
BOSTON – Northeast Hospital Corporation (Northeast), part of Beth Israel Lahey Health, has agreed to pay $1.9 million in civil penalties to resolve allegations that Northeast violated the Controlled Substance Act (the CSA) by failing to keep accurate records of controlled substances, including opioids. The CSA requires accurate inventorying and...
Diciembre 07, 2022
PRESS RELEASE

Dentist and TOBAY Worker Charged in 136-Count Indictment for Opioid Prescription Scheme

Noviembre 18, 2022
MINEOLA, N.Y. – Nassau County District Attorney Anne T. Donnelly and Drug Enforcement Administration Special Agent in Charge Frank A. Tarentino III and announced that a Nassau County dentist and a Town of Oyster Bay worker have been indicted for their roles in a scheme to sell opioid prescriptions during...
Noviembre 18, 2022
PRESS RELEASE

Pill Mill Operator Convicted for Oxycodone Diversion

Septiembre 08, 2022
NEW YORK - Damian Williams, the United States Attorney for the Southern District of New York, announced that a jury returned a guilty verdict yesterday against Purificacion Cristobal for her participation in a conspiracy to distribute oxycodone without a legitimate medical purpose acting outside the usual course of professional practice...
Septiembre 08, 2022
PRESS RELEASE

East Windsor Man Admits Role In Oxycodone Prescription Fraud Scheme

Julio 19, 2022
EAST WINDSOR, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, today announced that an East Windsor man has admitted his role in a scheme to acquire and distribute oxycodone obtained through fraudulent prescriptions. On July 5, 2022, JAYSON KEMP, 45, pleaded guilty before U.S. District...
Julio 19, 2022
PRESS RELEASE

Robeson County Man Sentenced to 10 Years for Distributing Thousands of Illegal Pills While Possessing Gun

Julio 06, 2022
RALEIGH, N.C. – A Robeson County man was sentenced today to 120 months in prison for conspiracy to distribute and possessing with the intent to distribute thousands of illegal prescription pills including oxycodone, oxymorphone, hydrocodone, and methadone. On February 16, 2021, Jeffrey Randal Brooks, Jr., pleaded guilty to the charges...
Julio 06, 2022
PRESS RELEASE

Jury Convicts State Lawmaker of COVID-19 Fraud Scheme at Springfield Health Care Charity

Junio 28, 2022
SPRINGFIELD, Mo. – A Missouri state representative was convicted by a federal trial jury today for a nearly $900,000 COVID-19 fraud scheme, as well as a separate $200,000 fraud scheme in which she made false claims about a fake stem cell treatment marketed through her clinics in southern Missouri, and...
Junio 28, 2022
PRESS RELEASE

Pharmacist Admits Filling Counterfeit Prescriptions Selling Oxycodone and Codeine in Exchange for Cash

Junio 28, 2022
NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a pharmacist and pharmacy owner pleaded guilty today to violating the Controlled Substances Act by filling fraudulent and counterfeit...
Junio 28, 2022
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Pleads Guilty to Conspiracy to Distribute and Dispense Oxycodone

Junio 16, 2022
Baltimore, Maryland – Norman Rosen, age 84, of Towson, Maryland, pleaded guilty today to conspiracy to distribute and dispense oxycodone in connection with his operation of Rosen-Hoffberg Rehabilitation and Pain Management Associates, P.A., where he was Medical Director and part-owner. The guilty plea was announced by Jarod Forget, Special Agent...
Junio 16, 2022
PRESS RELEASE

Richland Physician Sentenced for Conspiring to Distribute Medically Unnecessary Fentanyl Patches, Opioid Pills and Other Controlled Substances

Abril 28, 2022
SPOKANE, Wash. – Senior U.S. District Judge Edward F. Shea has sentenced Dr. Janet Sue Arnold, age 63, of Benton City, Washington, to 48 months in federal prison for conspiring to distribute and possess with intent to distribute opioid pain medications and other controlled substances without a legitimate medical purpose...
Abril 28, 2022
PRESS RELEASE

Greenville Woman Sentenced to More Than 10 Years in Oxycodone Conspiracy

Abril 21, 2022
GREENVILLE, SOUTH CAROLINA — Keowsha Golden, 36, of Greenville, was sentenced to more than 1o years in federal prison after pleading guilty to conspiracy to distribute oxycodone. Evidence presented to the Court showed that Golden obtained prescription paper and then forged physician information to write prescriptions for 30 milligram oxycodone...
Abril 21, 2022
Showing 1 - 10 of 19 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster